BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2947365)

  • 1. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin. Mechanism of action: in vitro studies.
    Hess AD; Colombani PM
    Prog Allergy; 1986; 38():198-221. PubMed ID: 2941763
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward understanding the mechanism of ciclosporin (cyclosporine) immunosuppression.
    Lorber MI
    Year Immunol; 1988; 3():291-302. PubMed ID: 3327316
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies on the immunosuppressive action of cyclosporine.
    Matsuura T; Uemura T; Kunikata S; Kanda H; Akiyama T; Kurita T
    Dev Toxicol Environ Sci; 1986; 14():149-52. PubMed ID: 2951243
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.
    Colombani PM; Robb A; Hess AD
    Science; 1985 Apr; 228(4697):337-9. PubMed ID: 3885394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity.
    Quesniaux VF; Schreier MH; Wenger RM; Hiestand PC; Harding MW; Van Regenmortel MH
    Eur J Immunol; 1987 Sep; 17(9):1359-65. PubMed ID: 3308488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues.
    Durette PL; Boger J; Dumont F; Firestone R; Frankshun RA; Koprak SL; Lin CS; Melino MR; Pessolano AA; Pisano J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):51-7. PubMed ID: 2966482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of cyclosporine binding by cyclophilin and calmodulin.
    Foxwell BM; Wong WC; Borel JF; Ryffel B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):873-5. PubMed ID: 2650286
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular characteristics of cyclophilin-cyclosporine interaction.
    Quesniaux VF; Schreier MH; Wenger RM; Hiestand PC; Harding MW; Van Regenmortel MH
    Transplantation; 1988 Aug; 46(2 Suppl):23S-28S. PubMed ID: 2970139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine and its analogue SDZ IMM 125 mediate very similar effects on T-cell activation--a comparative analysis in vitro.
    Baumann G; Andersen E; Quesniaux V; Eberle MK
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):43-8. PubMed ID: 1496687
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine-cyclophilin interaction.
    Quesniaux VF; Schreier MH; Wenger RM; Hiestand PC; Van Regenmortel MH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):58-62. PubMed ID: 3284106
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracellular targets of cyclosporine.
    Fairley JA
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1329-32; discussion 1332-4. PubMed ID: 2277142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin A.
    Ryffel B; Woerly G; Murray M; Eugster HP; Car B
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1074-83. PubMed ID: 8394698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine.
    Ryffel B
    Pharmacol Rev; 1990 Sep; 41(3):407-22. PubMed ID: 2185492
    [No Abstract]   [Full Text] [Related]  

  • 18. Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activation.
    Ryffel B; Woerly G; Quesniaux VF; Husi H; Foxwell BM
    Biochem Pharmacol; 1992 Mar; 43(5):953-60. PubMed ID: 1554393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
    J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.